137.50p-2.50 (-1.79%)28 Mar 2024, 14:16
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Faron Pharmaceuticals Oy Market & Company News

28.03.2024 07:00FARNIssue of Warrants to IPF Funding UpdateRNS
26.03.2024 10:00FARNFaron´s Annual Report 2023RNS
18.03.2024 11:41FARNFaron Pharmaceuticals shares jump on positive data from Bexmab studyAlliance
18.03.2024 10:05TUNE, CLON, FARNAIM WINNERS & LOSERS: Clontarf raises GBP400,000; Faron jumpsAlliance
18.03.2024 07:00FARNAdditional Positive Data from Phase 1 of BEXMABRNS
14.03.2024 07:00FARNFaron to Host BEXMAB WebcastReach
13.03.2024 20:49MACF, CORA, ELEGEARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian dealAlliance
13.03.2024 14:00FARNNotice of Annual General Meeting 2024RNS
13.03.2024 07:00FARNFinancial Statement January 1 to December 31 2023RNS
06.03.2024 16:06EGY, TRN, SUPRUK earnings, trading statements calendar - next 7 daysAlliance
04.03.2024 19:59BRH, CLA, FARNTRADING UPDATES: Beowulf raises funds for Kallak iron ore projectAlliance
04.03.2024 07:00FARNBinding commitments for convertible loansRNS
28.02.2024 16:00FARNReplacement - Update to 2024 Financial CalendarRNS
27.02.2024 21:12FARN, IUG, BENTRADING UPDATES: Armadale Capital eyes Mahenge project financingAlliance
27.02.2024 18:00FARNUpdate to Faron’s Financial Calendar for 2024RNS
22.02.2024 17:36OMI, FARN, AMIFEARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"Alliance
22.02.2024 14:26WEIR, VSVS, SPIUK earnings, trading statements calendar - next 7 daysAlliance
21.02.2024 14:00FARNContinued Negotiations Regarding Events of DefaultRNS
19.02.2024 11:23FARNFaron discloses events of default on debt obligations to lenderAlliance
19.02.2024 10:30FARNEvents of DefaultRNS
31.01.2024 07:00FARNFurther re: Exercise of optionsRNS
25.01.2024 20:09MSYS, NARF, FARNTRADING UPDATES: Microsaic completes acquisition; Narf revenue soarsAlliance
25.01.2024 07:00FARNBEXMAB Insights into Patient ProfilesRNS
19.01.2024 13:00FARNExercise of options - Issue of equityRNS
09.01.2024 10:56FARNFaron says first patient dosed in phase two Bexmab trial for cancerAlliance
09.01.2024 07:00FARNFirst Patient Dosed in Ph 2 of the BEXMAB TrialRNS
03.01.2024 07:00FARNPresentation at J.P. Morgan Healthcare ConferenceReach
22.12.2023 07:00FARNFaron’s Financial Calendar for 2024RNS
11.12.2023 12:01FARNFaron Pharmaceuticals hails positive results of cancer drug trialAlliance
11.12.2023 07:00FARNPhase 1 BEXMAB data presented at ASHRNS
07.12.2023 19:33FARNIN BRIEF: Faron Pharma celebrates publication of bexmarilimab resultsAlliance
07.12.2023 07:00FARNMATINS Trial in Cell Reports MedicineReach
04.12.2023 07:00FARNGrant of optionsRNS
06.11.2023 11:03FARNIN BRIEF: Faron Pharmaceuticals starts Phase 2 of Bexmab trialAlliance
06.11.2023 08:13FARNFaron Initiates Phase 2 Part of BEXMAB StudyRNS
06.11.2023 07:00FARNFaron Initiates Phase 2 Part of BEXMAB StudyRNS
02.11.2023 13:00FARNFaron to present data from BEXMAB study at ASHReach
30.10.2023 15:56CTG, VIP, ALTTRADING UPDATES: Bezant optimistic after Hope & Gorob estimateAlliance
27.10.2023 13:00FARNManager's transactionsRNS
27.10.2023 07:15FARNExercise of optionsRNS
27.10.2023 07:00FARNResults of PlacingRNS
26.10.2023 16:30FARNProposed Issue and PlacingRNS
11.10.2023 14:01FARNIN BRIEF: Faron Pharmaceuticals' Bexmarilimab shows 50% remission rateAlliance
11.10.2023 07:00FARNFaron Announces Positive BEXMAB Study UpdateRNS
03.10.2023 07:00FARNFaron to host webcast on new BEXMAB study dataReach
22.09.2023 16:00FARNBoard ChangesRNS
22.09.2023 11:00FARNResults of EGMRNS
21.09.2023 12:12TRAK, FTC, 88ETRADING UPDATES: Faron appoints Birge Berns as interim medical officerAlliance
21.09.2023 07:00FARNFaron Appoints Interim Chief Medical OfficerRNS
15.09.2023 15:46OIT, TIFS, FARNUK shareholder meetings calendar - next 7 daysAlliance
08.09.2023 07:00FARNChange in the Board of DirectorsRNS
06.09.2023 07:00FARNFaron to Present at H.C. Wainwright ConferenceReach
05.09.2023 14:22FARN, EVGEvgen Pharma hires interim CFO from Faron, chair to retire this monthAlliance
01.09.2023 10:00FARNNotice of EGMRNS
31.08.2023 14:00FARNExercise of optionsRNS
29.08.2023 10:23FARN, PANRAIM WINNERS & LOSERS: Pelatro plummets on delisting plansAlliance
29.08.2023 10:15FARNFaron shares surge on FDA drug designation; loss widens on costsAlliance
29.08.2023 07:01FARNFaron 2023 Half-Year Financial ResultsRNS
29.08.2023 07:00FARNFDA Orphan Drug Designation for BexmarilimabRNS
22.08.2023 15:46PRTC, FARN, DALUK earnings, trading statements calendar - next 7 daysAlliance
04.08.2023 07:00FARNNotice of Half-Year Financial ResultsRNS
02.08.2023 07:00FARNFaron to Participate at Canaccord ConferenceReach
25.07.2023 07:00FARNGrant of OptionsRNS
19.07.2023 10:27FARNFaron Pharmaceuticals sees positive data from phase 1 BEXMAB trialAlliance
19.07.2023 07:01FARNFaron to Hold BEXMAB Study Conference CallReach
19.07.2023 07:00FARNBEXMAB study updateRNS
30.06.2023 16:52FARNHolding(s) in CompanyRNS
29.06.2023 18:55RNEW, JSE, FARNTRADING UPDATES: Ecofin US Renewables expects to pay reduced dividendAlliance
29.06.2023 07:00FARNAnnouncement of PlacingRNS
12.06.2023 07:00FARNExercise of optionsRNS
09.06.2023 14:34RGL, IES, GUNTRADING UPDATES: Medica shareholders back takeover; Arecor optimisticAlliance
09.06.2023 08:00FARNNew biomarker data from BEXMAB study at EHA2023Reach
05.06.2023 07:00FARNBoard Member to Assume Transactional Advisor RoleRNS
24.04.2023 14:21FARNFaron Pharmaceuticals test data shows efficacy of bexmarilimabAlliance
24.04.2023 07:00FARNBexmarilimab Efficacy and Safety in MATINS TrialReach
Showing 1 to 75 of 232